GRRR Stock Tracks Worst Rout In Over A Year — Here’s What Investors Are Watching Now

• GRRR shares rebounded premarket Thursday after falling in the previous session on a $125 million convertible bond deal.
• The 7.50% convertible notes mature in 2031 and initially convert at $25.48 per share.
• Gorilla will use the proceeds to fund its NeutraDC Batam data center project in Indonesia.

Shares of Gorilla Technology Group, Inc. (GRRR) rose 1% premarket on Thursday after sliding on a $125 million convertible bond deal in the previous session, as fresh filings showed that CEO Jay Chandan and four directors received a combined 166,371 shares through the vesting of restricted stock units (RSU).

GRRR stock has crashed 34% so far this week, heading for its worst week in 18 months. 

GRRR Insiders Receive Over 166K Shares 

Fresh filings on Wednesday showed that Chandan received 119,178 GRRR) ordinary shares on Monday after RSUs vested under the company’s 2023 Omnibus Incentive Plan. Director Ruth Kelly received 14,301 shares, while Keith Levy, Gregg Walker and Evan Medeiros each received 10,964 shares. Chandan directly owned 1.21 million shares after the vesting. Kelly’s holdings rose to 135,928 shares, while Walker owned 55,572 shares, Levy 52,075 shares and Medeiros 32,107 shares. 

Gorilla shares fell on Wednesday after the company priced $125 million of 7.50% senior unsecured convertible notes due 2031 in a private placement to institutional investors. The offering is expected to close around Friday. The notes initially convert at $25.48 per share, a 52% premium to GRRR’s Tuesday closing price of $16.77. The conversion price can reset downward to a floor of $8 or upward to a cap of about $31.85. Interest is payable semiannually in cash or, under certain conditions, ordinary shares. 

Gorilla Targets $2.5B AI Contract

Gorilla plans to use the net proceeds to secure committed data center capacity and begin funding equipment purchases for its NeutraDC Batam project in Indonesia. The project is for a five-year AI compute agreement announced last month with an undisclosed high investment-grade global tech customer. The company said that the contract represents $2.5 billion in expected revenue over five years. The first phase, involving about 1,000 Nvidia B300 GPU servers, is expected to generate $1.3 billion.

Initial deployment is targeted for September, followed by a second tranche in December. The remaining deployment is expected during the first half of 2027. The company previously said that the financing offers covered about 70% of expected GPU, networking and related infrastructure costs.

Gorilla Expands AI Financing Platform

Earlier this month, Gorilla completed its acquisition of Shackleton Finance and launched Gorilla Tech Capital, a regulated platform to raise institutional money for AI infrastructure, data centers and GPU-as-a-Service projects. The platform targets pension funds, sovereign wealth funds, insurers and family offices, while reducing Gorilla’s reliance on dilutive equity raises.

Gorilla also raised its second-quarter revenue outlook in late June to at least $44 million, compared with external estimates of about $33.9 million. This represents growth of over 55% from the first quarter and more than 100% year-over-year.

How Do Retail Traders Feel About GRRR?

On Stocktwits, retail sentiment for GRRR flipped ‘bullish’ from ‘bearish’ levels a day ago amid an 872% surge in 24-hour message volumes.

One user said, “$GRRR No investment is without risk, and GRRR is no exception.  It's a high beta, low float, and high risk/reward play, and not intended for faint-hearted investors! The play here is very simple: timely, perfect execution.  If Jay and the team play this flawlessly, it's certainly a multi-bagger. “

Another user said, “$GRRR Jay has some explaining to do. That's for certain. Updates should be provided next month during ER call. Keep in mind, Shackleton (Gorilla Tech Capital) has just been acquired. Expecting some heavy investments to roll in to funds these DC projects.”

GRRR stock has declined 43% over the past year. 

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Read Next: SLS, IBRX Rise Overnight: Retail Bets On Big Pharma Buyouts As J&J Chases No. 1 Oncology Spot